-
1
-
-
0035114558
-
Cancer Statistics, 2001
-
Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer Statistics, 2001. CA Cancer J Clin 2001;51:15-36.
-
(2001)
CA Cancer J Clin
, vol.51
, pp. 15-36
-
-
Greenlee, R.T.1
Hill-Harmon, M.B.2
Murray, T.3
-
2
-
-
0029002348
-
Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients
-
Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995;221:721-731.
-
(1995)
Ann Surg
, vol.221
, pp. 721-731
-
-
Yeo, C.J.1
Cameron, J.L.2
Lillemoe, K.D.3
-
3
-
-
0032111677
-
Imaging techniques in the evaluation of adenocarcinoma of the pancreas
-
Brand RE, Matamoros A. Imaging techniques in the evaluation of adenocarcinoma of the pancreas. Dig Dis 1998;16:242-252.
-
(1998)
Dig Dis
, vol.16
, pp. 242-252
-
-
Brand, R.E.1
Matamoros, A.2
-
4
-
-
0018214433
-
A prospective study of glucose tolerance, insulin, C-peptide and glucagon responses in patients with pancreatic carcinoma
-
Schwarz SS, Zeidler A, Moossa AR, et al. A prospective study of glucose tolerance, insulin, C-peptide and glucagon responses in patients with pancreatic carcinoma. Dig Dis Sci 1978;23:1107-1114.
-
(1978)
Dig Dis Sci
, vol.23
, pp. 1107-1114
-
-
Schwarz, S.S.1
Zeidler, A.2
Moossa, A.R.3
-
5
-
-
0027521023
-
Pancreatic cancer is associated with impaired glucose metabolism
-
Permert J, Ihse I, Jorfeldt L, et al. Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 1993;159:101-107.
-
(1993)
Eur J Surg
, vol.159
, pp. 101-107
-
-
Permert, J.1
Ihse, I.2
Jorfeldt, L.3
-
6
-
-
0028054783
-
Islet amyloid polypeptide in patients with pancreatic cancer and diabetes
-
Permert J, Larsson J, Westermark GT, et al. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Eng J Med 1994;330:313-318.
-
(1994)
N Eng J Med
, vol.330
, pp. 313-318
-
-
Permert, J.1
Larsson, J.2
Westermark, G.T.3
-
7
-
-
0027538119
-
Islet amyloid polypeptide-like immunoreactivity in human tissue and endocrine tumors
-
Bretherton-Watt D, Ghatei MA, Bloom SE, et al. Islet amyloid polypeptide-like immunoreactivity in human tissue and endocrine tumors. J Clin Endocrinol Metab 1993;76:1072-1074.
-
(1993)
J Clin Endocrinol Metab
, vol.76
, pp. 1072-1074
-
-
Bretherton-Watt, D.1
Ghatei, M.A.2
Bloom, S.E.3
-
8
-
-
0025287442
-
Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans
-
Butler PC, Chou J, Carter WB, et al. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 1990;39:752-756.
-
(1990)
Diabetes
, vol.39
, pp. 752-756
-
-
Butler, P.C.1
Chou, J.2
Carter, W.B.3
-
9
-
-
0025967810
-
Plasma islet amyloid polypeptide (amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients
-
Sanke T, Hanabusa T, Nakano Y, et al. Plasma islet amyloid polypeptide (amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991;34:129-132.
-
(1991)
Diabetologia
, vol.34
, pp. 129-132
-
-
Sanke, T.1
Hanabusa, T.2
Nakano, Y.3
-
10
-
-
0025957988
-
Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin
-
Hartter E, Svoboda T, Ludvik B, et al. Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin. Diabetologia 1991;34:52-54.
-
(1991)
Diabetologia
, vol.34
, pp. 52-54
-
-
Hartter, E.1
Svoboda, T.2
Ludvik, B.3
-
11
-
-
0026595151
-
Islet amyloid polypeptide plasma concentrations in individuals at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus
-
Eriksson J, Nakazato M, Miyazato M, et al. Islet amyloid polypeptide plasma concentrations in individuals at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992;35:291-293.
-
(1992)
Diabetologia
, vol.35
, pp. 291-293
-
-
Eriksson, J.1
Nakazato, M.2
Miyazato, M.3
-
13
-
-
0034837496
-
Sensitivity and specificity of CA 19-9 and islet amyloid polypeptide (IAPP) for symptomatic pancreatic cancer (PC). Abstract for American Pancreatic Association Mtg 1998
-
Chari S, Klee GG, Miller LJ, et al. Sensitivity and specificity of CA 19-9 and islet amyloid polypeptide (IAPP) for symptomatic pancreatic cancer (PC). Abstract for American Pancreatic Association Mtg 1998. Gastroenterology 2001;121:640-645.
-
(2001)
Gastroenterology
, vol.121
, pp. 640-645
-
-
Chari, S.1
Klee, G.G.2
Miller, L.J.3
-
14
-
-
0026513764
-
Diagnosis of pancreatic carcinoma
-
Niederau C, Grendell JH. Diagnosis of pancreatic carcinoma. Pancreas 1992;7:66-86.
-
(1992)
Pancreas
, vol.7
, pp. 66-86
-
-
Niederau, C.1
Grendell, J.H.2
-
15
-
-
0025307965
-
The clinical utility of the CA 19-9 tumor-associated antigen
-
Steinberg W. The clinical utility of the CA 19-9 tumor-associated antigen. Am J Gastroenterol 1990;85:350-355.
-
(1990)
Am J Gastroenterol
, vol.85
, pp. 350-355
-
-
Steinberg, W.1
-
16
-
-
0028294001
-
Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma
-
Kondo H, Sugano K, Fukayama N, et al. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma. Cancer 1994;73:1589-1594.
-
(1994)
Cancer
, vol.73
, pp. 1589-1594
-
-
Kondo, H.1
Sugano, K.2
Fukayama, N.3
|